An observational study in Cancer, DNA G-quadruplex and Methylation, sponsored by Zhongnan Hospital. Withdrawn at 1 site in China. Open to participants aged 42 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-07.
Sponsored by Zhongnan Hospital · Observational
This study aims to evaluate the early diagnosis value of G-quadruplex DNA methylation in patients with cancer.
Global DNA hypomethylation is a hallmark of most cancers that occurs early during oncogenesis. We would like to investigate whether cancer-specific transcription factor binding to DNA G-quadruplex drives DNA hypomethylation in cancer. In this observational study, we would like to clarify whether DNA hypomethylation around G-quadruplex loci in cell-free DNA could be detected in early-stage cancer patients from healthy donors with high sensitivity and specificity.
Zhongnan Hospital is the lead sponsor of 103 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healthy volunteers, aged 42 years or older, who are asymptomatic as determined by medical examination and willing to participate voluntarily in the study with signed informed consent.
Exclusion Criteria:
Asymptomatic medical examination population.
Other: G4 DNAm test
Detection of DNA methylation (DNAm) around G-quadruplex loci in cell-free DNA from blood.
G-quadruplex DNAm score
Detection of DNAm around G-quadruplex loci in cell-free DNA from blood.
Time frame: 2024.04.30-2024.09.30
This study is withdrawn, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zhongnan Hospital